 | • レポートコード：GIR-2104Z07642 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、炎症性腸疾患治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。炎症性腸疾患治療薬の種類別市場規模（アミノサリチル酸塩、抗生物質、コルチコステロイド、免疫調節剤、生物製剤、その他）、用途別市場規模（潰瘍性大腸炎、クローン病、不確定性大腸炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・炎症性腸疾患治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Biocon Ltd、Roche、Johnson and Johnson、Mylan Pharmaceuticals、Novartis AG、Pfizer、Quest Medical、Sanofi、Takeda Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アミノサリチル酸塩、抗生物質、コルチコステロイド、免疫調節剤、生物製剤、その他 ・用途別分析2016年-2026年：潰瘍性大腸炎、クローン病、不確定性大腸炎、その他 ・炎症性腸疾患治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・炎症性腸疾患治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・炎症性腸疾患治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・炎症性腸疾患治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・炎症性腸疾患治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Inflammatory Bowel Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Inflammatory Bowel Disease Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Inflammatory Bowel Disease Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Inflammatory Bowel Disease Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Amino-salicylates
Antibiotics
Corticosteroids
Immunomodulators
Biologics
Others
Market segment by Application can be divided into
Ulcerative Colitis
Crohns Disease
Indeterminate Colitis
Others
The key market players for global Inflammatory Bowel Disease Drugs market are listed below:
Abbott Laboratories
Biocon Ltd
Roche
Johnson and Johnson
Mylan Pharmaceuticals
Novartis AG
Pfizer
Quest Medical
Sanofi
Takeda Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Inflammatory Bowel Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inflammatory Bowel Disease Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Amino-salicylates
1.2.3 Antibiotics
1.2.4 Corticosteroids
1.2.5 Immunomodulators
1.2.6 Biologics
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Inflammatory Bowel Disease Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Ulcerative Colitis
1.3.3 Crohns Disease
1.3.4 Indeterminate Colitis
1.3.5 Others
1.4 Global Inflammatory Bowel Disease Drugs Market Size & Forecast
1.4.1 Global Inflammatory Bowel Disease Drugs Sales in Value (2016-2026))
1.4.2 Global Inflammatory Bowel Disease Drugs Sales in Volume (2016-2026)
1.4.3 Global Inflammatory Bowel Disease Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Inflammatory Bowel Disease Drugs Production Capacity Analysis
1.5.1 Global Inflammatory Bowel Disease Drugs Total Production Capacity (2016-2026)
1.5.2 Global Inflammatory Bowel Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inflammatory Bowel Disease Drugs Market Drivers
1.6.2 Inflammatory Bowel Disease Drugs Market Restraints
1.6.3 Inflammatory Bowel Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Product and Services
2.1.4 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Biocon Ltd
2.2.1 Biocon Ltd Details
2.2.2 Biocon Ltd Major Business
2.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Product and Services
2.2.4 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Inflammatory Bowel Disease Drugs Product and Services
2.3.4 Roche Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Johnson and Johnson
2.4.1 Johnson and Johnson Details
2.4.2 Johnson and Johnson Major Business
2.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Product and Services
2.4.4 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Mylan Pharmaceuticals
2.5.1 Mylan Pharmaceuticals Details
2.5.2 Mylan Pharmaceuticals Major Business
2.5.3 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product and Services
2.5.4 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Inflammatory Bowel Disease Drugs Product and Services
2.6.4 Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Inflammatory Bowel Disease Drugs Product and Services
2.7.4 Pfizer Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Quest Medical
2.8.1 Quest Medical Details
2.8.2 Quest Medical Major Business
2.8.3 Quest Medical Inflammatory Bowel Disease Drugs Product and Services
2.8.4 Quest Medical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Inflammatory Bowel Disease Drugs Product and Services
2.9.4 Sanofi Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Takeda Pharmaceutical
2.10.1 Takeda Pharmaceutical Details
2.10.2 Takeda Pharmaceutical Major Business
2.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product and Services
2.10.4 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Inflammatory Bowel Disease Drugs Sales by Manufacturer
3.1 Global Inflammatory Bowel Disease Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Inflammatory Bowel Disease Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Inflammatory Bowel Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Inflammatory Bowel Disease Drugs Manufacturer Market Share
3.4.2 Top 6 Inflammatory Bowel Disease Drugs Manufacturer Market Share
3.5 Global Inflammatory Bowel Disease Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Inflammatory Bowel Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inflammatory Bowel Disease Drugs Market Size by Region
4.1.1 Global Inflammatory Bowel Disease Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Inflammatory Bowel Disease Drugs Revenue by Region (2016-2026)
4.2 North America Inflammatory Bowel Disease Drugs Revenue (2016-2026)
4.3 Europe Inflammatory Bowel Disease Drugs Revenue (2016-2026)
4.4 Asia-Pacific Inflammatory Bowel Disease Drugs Revenue (2016-2026)
4.5 South America Inflammatory Bowel Disease Drugs Revenue (2016-2026)
4.6 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Inflammatory Bowel Disease Drugs Sales in Volume by Type (2016-2026)
5.2 Global Inflammatory Bowel Disease Drugs Revenue by Type (2016-2026)
5.3 Global Inflammatory Bowel Disease Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Inflammatory Bowel Disease Drugs Sales in Volume by Application (2016-2026)
6.2 Global Inflammatory Bowel Disease Drugs Revenue by Application (2016-2026)
6.3 Global Inflammatory Bowel Disease Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Inflammatory Bowel Disease Drugs Sales by Type (2016-2026)
7.2 North America Inflammatory Bowel Disease Drugs Sales by Application (2016-2026)
7.3 North America Inflammatory Bowel Disease Drugs Market Size by Country
7.3.1 North America Inflammatory Bowel Disease Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Inflammatory Bowel Disease Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Inflammatory Bowel Disease Drugs Sales by Type (2016-2026)
8.2 Europe Inflammatory Bowel Disease Drugs Sales by Application (2016-2026)
8.3 Europe Inflammatory Bowel Disease Drugs Market Size by Country
8.3.1 Europe Inflammatory Bowel Disease Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Inflammatory Bowel Disease Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Inflammatory Bowel Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Inflammatory Bowel Disease Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Inflammatory Bowel Disease Drugs Sales by Type (2016-2026)
10.2 South America Inflammatory Bowel Disease Drugs Sales by Application (2016-2026)
10.3 South America Inflammatory Bowel Disease Drugs Market Size by Country
10.3.1 South America Inflammatory Bowel Disease Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Inflammatory Bowel Disease Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Inflammatory Bowel Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Inflammatory Bowel Disease Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Inflammatory Bowel Disease Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Inflammatory Bowel Disease Drugs Typical Distributors
12.3 Inflammatory Bowel Disease Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Inflammatory Bowel Disease Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Inflammatory Bowel Disease Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Inflammatory Bowel Disease Drugs Product and Services
Table 6. Abbott Laboratories Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Biocon Ltd Major Business
Table 9. Biocon Ltd Inflammatory Bowel Disease Drugs Product and Services
Table 10. Biocon Ltd Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Inflammatory Bowel Disease Drugs Product and Services
Table 14. Roche Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson and Johnson Major Business
Table 17. Johnson and Johnson Inflammatory Bowel Disease Drugs Product and Services
Table 18. Johnson and Johnson Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Pharmaceuticals Major Business
Table 21. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product and Services
Table 22. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 24. Novartis AG Major Business
Table 25. Novartis AG Inflammatory Bowel Disease Drugs Product and Services
Table 26. Novartis AG Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Inflammatory Bowel Disease Drugs Product and Services
Table 30. Pfizer Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Quest Medical Basic Information, Manufacturing Base and Competitors
Table 32. Quest Medical Major Business
Table 33. Quest Medical Inflammatory Bowel Disease Drugs Product and Services
Table 34. Quest Medical Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Inflammatory Bowel Disease Drugs Product and Services
Table 38. Sanofi Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Takeda Pharmaceutical Major Business
Table 41. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product and Services
Table 42. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Inflammatory Bowel Disease Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Inflammatory Bowel Disease Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Inflammatory Bowel Disease Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Inflammatory Bowel Disease Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Inflammatory Bowel Disease Drugs Production Site of Key Manufacturer
Table 48. Global Inflammatory Bowel Disease Drugs Sales by Region (2016-2021e) & (K Units)
Table 49. Global Inflammatory Bowel Disease Drugs Sales by Region (2021-2026) & (K Units)
Table 50. Global Inflammatory Bowel Disease Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Inflammatory Bowel Disease Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Inflammatory Bowel Disease Drugs Sales by Type (2016-2021e) & (K Units)
Table 53. Global Inflammatory Bowel Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Global Inflammatory Bowel Disease Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Inflammatory Bowel Disease Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Inflammatory Bowel Disease Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Inflammatory Bowel Disease Drugs Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Inflammatory Bowel Disease Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Global Inflammatory Bowel Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Global Inflammatory Bowel Disease Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Inflammatory Bowel Disease Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Inflammatory Bowel Disease Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Inflammatory Bowel Disease Drugs Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Inflammatory Bowel Disease Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. North America Inflammatory Bowel Disease Drugs Sales by Country (2021-2026) & (K Units)
Table 66. North America Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Inflammatory Bowel Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Inflammatory Bowel Disease Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. North America Inflammatory Bowel Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 70. North America Inflammatory Bowel Disease Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. North America Inflammatory Bowel Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Europe Inflammatory Bowel Disease Drugs Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Inflammatory Bowel Disease Drugs Sales by Country (2021-2026) & (K Units)
Table 74. Europe Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Inflammatory Bowel Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Inflammatory Bowel Disease Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Inflammatory Bowel Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Europe Inflammatory Bowel Disease Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Inflammatory Bowel Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Inflammatory Bowel Disease Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Inflammatory Bowel Disease Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 88. South America Inflammatory Bowel Disease Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. South America Inflammatory Bowel Disease Drugs Sales by Country (2021-2026) & (K Units)
Table 90. South America Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Inflammatory Bowel Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Inflammatory Bowel Disease Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. South America Inflammatory Bowel Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 94. South America Inflammatory Bowel Disease Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. South America Inflammatory Bowel Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Inflammatory Bowel Disease Drugs Typical Distributors
Table 107. Inflammatory Bowel Disease Drugs Typical Customers
List of Figures
Figure 1. Inflammatory Bowel Disease Drugs Picture
Figure 2. Global Inflammatory Bowel Disease Drugs Sales Market Share by Type in 2020
Figure 3. Amino-salicylates
Figure 4. Antibiotics
Figure 5. Corticosteroids
Figure 6. Immunomodulators
Figure 7. Biologics
Figure 8. Others
Figure 9. Global Inflammatory Bowel Disease Drugs Sales Market Share by Application in 2020
Figure 10. Ulcerative Colitis
Figure 11. Crohns Disease
Figure 12. Indeterminate Colitis
Figure 13. Others
Figure 14. Global Inflammatory Bowel Disease Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Inflammatory Bowel Disease Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Inflammatory Bowel Disease Drugs Sales (2016-2026) & (K Units)
Figure 36. Global Inflammatory Bowel Disease Drugs Production Capacity (2016-2026) & (K Units)
Figure 37. Global Inflammatory Bowel Disease Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Inflammatory Bowel Disease Drugs Market Drivers
Figure 39. Inflammatory Bowel Disease Drugs Market Restraints
Figure 40. Inflammatory Bowel Disease Drugs Market Trends
Figure 41. Global Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturer in 2020
Figure 42. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Manufacturer in 2020
Figure 43. Inflammatory Bowel Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Inflammatory Bowel Disease Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Inflammatory Bowel Disease Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Inflammatory Bowel Disease Drugs Sales Market Share by Region (2016-2026)
Figure 47. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Region (2016-2026)
Figure 48. North America Inflammatory Bowel Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Europe Inflammatory Bowel Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Inflammatory Bowel Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 51. South America Inflammatory Bowel Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Global Inflammatory Bowel Disease Drugs Sales Market Share by Type (2016-2026)
Figure 54. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Type (2016-2026)
Figure 55. Global Inflammatory Bowel Disease Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2026)
Figure 57. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Application (2016-2026)
Figure 58. Global Inflammatory Bowel Disease Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2026)
Figure 60. North America Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 61. North America Inflammatory Bowel Disease Drugs Sales Market Share by Type (2016-2026)
Figure 62. North America Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2026)
Figure 63. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2026)
Figure 64. Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Type (2016-2026)
Figure 66. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Inflammatory Bowel Disease Drugs Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2026)
Figure 72. South America Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 73. South America Inflammatory Bowel Disease Drugs Sales Market Share by Type (2016-2026)
Figure 74. South America Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の炎症性腸疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Bowel Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Therapeutics Market The global Inflammatory Bowel Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の炎症性腸疾患市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- 世界の炎症性腸疾患（IBD）治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Treatment Market The global Inflammatory Bowel Disease Treatment market size is projected to reach US$ 15660 million by 2026, from US$ 13310 million in 2019, at a CAGR of 2.3% during 2021-2026. With industry-standard accuracy in analysi…